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Arboviral diseases are expanding worldwide, yet global surveillance is often limited due 
to diplomatic and cultural barriers between nations. With human encroachment into new 
habitats, mosquito-borne viruses are also invading new areas. The actual prevalence of 
expanding arboviruses is unknown in Pakistan due to inappropriate diagnosis and poor 
testing for arboviral diseases. The primary objective of this study was to document evi-
dence of flavivirus infections as the cause of undifferentiated fever in Pakistan. Through 
a cooperative effort between the USA and Pakistan, patient exposure to dengue virus 
(DENV), West Nile virus (WNV), and Japanese encephalitis virus (JEV) was examined in 
Sindh Province for the first time in decades. Initial results from the 2015 arbovirus season 
consisting of a cross-sectional study of 467 patients in 5 sites, DENV NS1 antigen was 
identified in 63 of the screened subjects, WNV IgM antibodies in 16 patients, and JEV 
IgM antibodies in 32 patients. In addition, a number of practical findings were made 
including (1) in silico optimization of RT-PCR primers for flavivirus strains circulating in 
the Middle East, (2) shipping and storage of RT-PCR master mix and other reagents at 
ambient temperature, (3) Smart phone applications for the collection of data in areas 
with limited infrastructure, and (4) fast and reliable shipping for transport of reagents and 
specimens to and from the Middle East. Furthermore, this work is producing a group of 
highly trained local scientists and medical professionals disseminating modern scientific 
methods and more accurate diagnostic procedures to the community.
Keywords: arbovirus, flavivirus, dengue viruses, Japanese encephalitis virus, West nile virus, transboundary 
diseases
inTrODUcTiOn
Political boundaries do not constrain human, animal, or plant diseases. As humans and animals 
migrate across these borders, their associated diseases relocate in tandem. Newly encroaching 
diseases are often overlooked because of limited surveillance, political motivation, resources, and 
infrastructure (1). Collaboration of health and scientific professionals from different countries 
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occurs in a politically neutral atmosphere that can have rapid 
positive and sustainable impacts on human and animal health 
and the control of emerging diseases (2, 3). The growth in sci-
entific personnel and infrastructure is essential to decrease the 
movement of diseases that threaten public health (1, 4–7). Many 
outbreaks since 1990 like prion disease in the UK, West Nile virus 
(WNV) in the America’s, and avian H5N2 in Canada and the US 
have been economically destabilizing and highlight the need for 
transboundary collaboration (8).
In the past decade, mosquito-borne viral diseases have 
emerged in many new locales, rapidly attaining endemic status. 
In Pakistan, arboviral diseases are frequently overlooked or 
misdiagnosed because of the vague symptoms and extensive dif-
ferential diagnoses, which overlap with many other pathologies, 
such as Crimean-Congo Hemorrhagic fever (CCHF), malaria, 
hepatitis C virus infection, Alkhurma virus, Kyasanur forest 
virus disease, rickettsiosis, ehrlichiosis, leptospirosis, typhoid 
fever, meningococcemia, borreliosis, Q fever, and influenza. 
Furthermore, manifestations of arboviral disease mimic other 
febrile diseases and severe disease can present as a hemorrhagic 
illness [dengue virus (DENV), yellow fever virus, Zika virus, 
and Lassa fever virus], neurological disease (WNV, DENV), or 
arthritis (chikungunya virus, Zika virus, and DENV) (9, 10). 
Because vaccines or antivirals do not exist for most of these 
viruses, surveillance becomes an essential part of control via 
detection and communication. The cornerstone of active and 
passive surveillance is accurate diagnostic assessment (9, 10).
There has been limited published data for arbovirus surveil-
lance in Pakistan. Historically, only the presence of DENV 
subtypes 1 and 2 were detected in isolated outbreaks in Pakistan 
in the twentieth century (11, 12). Since 2005, all four subtypes of 
DENV have spread throughout the country (12–15). In neigh-
boring Punjab province, the seroprevalence of DENV in patients 
was 42.63% in 2013 (16). The WHO lists Japanese encephalitis 
virus (JEV) as active in Pakistan (17), although most reports 
still indicate JEV activity mostly along the northern Pakistan–
India border (10, 18–20). JEV is likely circulating in Pakistan 
at this time, but limited information exists regarding the actual 
disease burden JEV contributes to human health in Pakistan. 
In the early 2000s, 25% of the Pakistani military personnel who 
tested seropositive for JEV demonstrated cross-reactivity with 
WNV and thus a true determination of infection could not be 
verified (21). WNV has been detected in Pakistan since 1980s. 
Epidemiological work performed 20  years ago indicated that 
WNV antibodies were present in over 40% of the human popula-
tion in Punjab province (21). Recently, a 55% seropositivity rate 
was detected in horses in Punjab province (18, 20–24). This high 
seroprevalence in horses suggests that WNV is also circulating 
in humans.
Described here are the initial data of a biological engage-
ment program (BEP) implemented between Pakistan (Aga 
Khan University, Karachi, Pakistan) and the US (University 
of Florida, Gainesville, FL, USA) to perform a multisite study 
examining possible arboviral causes of febrile disease in citizens 
of Sindh province. Via a “train the trainer” format, this project 
aimed to provide Pakistani collaborators with training for virus 
surveillance and diagnostics in order to assess the prevalence of 
flaviviruses (DENV, WNV, and JEV) in Pakistan. The primary 
objective of this study was to document evidence of the above 
mentioned viral infections as causes of undifferentiated fever in 
order to build capacity for laboratory diagnosis and surveillance 
within Pakistan.
MaTerials anD MeThODs
A cross-sectional, observational study was performed to identify 
which arboviruses (DENV, WNV, and JEV) were the cause of 
acute undifferentiated febrile illness in selected basic health 
units and/or district hospitals of the Sindh region of Pakistan. 
A total of 1,000 patients (250/year) patients were targeted for 
enrollment under informed consent procedures that were 
reviewed and approved by the Ethics Review Committee, Aga 
Khan University (#3183-PAT-ERC-14) and the Institutional 
Review Board, University of Florida (#201500908). All enrolled 
subjects gave written informed consent in accordance with the 
Declaration of Helsinki. Patients were recruited with a case 
definition developed by the WHO and modified by the Pakistan 
Ministry of Health to incorporate syndromic findings of acute 
hemorrhagic fever, acute flaccid paralysis, and unexplained fever 
(25). Patient enrollment was performed during the monsoon 
season (May–October) during 2015. All patients, males and 
females between 10 and 50 years age meeting the case definition 
on the day of enrollment, were eligible for the study. Patients 
younger than 10 and older than 50 years of age and patients who 
tested positive for CCHV, influenza, malaria, tuberculosis, and 
bacterial septicemia during routine hospital admittance proce-
dures were excluded (Figure 1). Briefly, all patients were tested 
for DENV antigen unless affected primarily by neurological 
abnormalities. If positive, serum was tested for DENV subtype 
by RT-PCR. All negative sera were tested via IgM capture ELISA 
for JEV and WNV.
study sites
Five study sites were established and personnel trained 
throughout the Sindh province in Pakistan (Figure  2). 
These sites included four medical colleges including Ghulam 
Mohammad Mahar Medical College (Sukkur, Pakistan), CMC 
Teaching Hospital (Larkana, Pakistan), and Muhammed 
Medical College Hospital (Mirpurkhas, Pakistan). Enrollment 
of study subjects was also established at a civil hospital in 
Hyderabad, Pakistan.
Data collection and Processing 
Procedures
Originally, for communication within Pakistan between sites, 
networked computers were planned as the primary mode of 
reporting of test results. Connectivity was found to be a major 
issue; even if access was available, there were frequent interrup-
tions and limited technological support. Android mobile phones 
provided an alternative for surveillance data collection and 
transmission (Epicollect®, http://www.epicollect.net/, Wellcome 
Trust, Imperial College London). At the study sites, patient 
information was collected on hard copy forms and de-identified 
FigUre 2 | locations of study sites throughout sindh, Pakistan. 
(Image obtained at https://en.wikipedia.org/wiki/Sindh#/media/File:Sindh_in_
Pakistan_%28claims_hatched%29.svg)
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FigUre 1 | Work flow for flavivirus exposure screening of enrolled 
patient samples.
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data were stored on smart phones by a dedicated to a study 
medical officer and synced daily to a secure homepage on the 
Epicollect website.
antigen and antibody screening Tests
Standard operating procedures were developed that follow pub-
lished WHO/CDC guidelines or publications that were optimized 
for detecting Asian variants of arbovirus (25). Primary DENV 
screening in patients was performed using a commercially avail-
able antigen capture test (Panbio Dengue Early Rapid Test, Alere, 
Waltham, MA, USA). IgM capture ELISA testing was performed 
using commercial assays for WNV and JEV (InBios, Seattle, WA, 
USA) following the manufacturer’s instructions.
real-Time Pcr
For detection of nucleic acids of DENV, primer sequences were 
constructed for stains circulating in Pakistan via addition of 
degenerate nucleotides (Table  1) (26). Primers, standards, and 
controls were developed using synthetic DNA targets of the vari-
ous portions of the viral genomes (Table 2) and real-time PCR 
was performed using a commercial master mix (BioRad iTaq 
Universal Probes Supermix, BioRad, Hercules, CA, USA) and a 
commercial real-time PCR machine (BioRad CFX 96, BioRad). 
All enrolled patients were screened for DENV via RT-PCR to 
identify DENV subtype.
resUlTs
antigen and antibody screening Tests
As of this time, the five sites have enrolled a total of 467 participants. 
DENV antigen, using the DENV NS1 Early Rapid Test, was found 
in 63 of the enrolled patients (Table 3). WNV IgM antibodies were 
detected in 16 of 241 screened individuals and JEV IgM antibodies 
in 32 of 414 screened patients (Table 3). DENV was detected at 
all sights except Sukkur. Karachi had the highest DENV exposure 
with DENV antigen detected in 53 of 176 screened patients. Febrile 
patients with WNV exposure were found at four sites with eight of 
the patients living in Karachi, two in Hyderabad, two in Larkana, 
and one in Mirpurkhas (Table 4). JEV exposure was identified in 
21 patients living in Karachi, 6 in Hyderabad, 1 in Mirpurkhas, 1 
in Sukkur, and 1 patient in Larkana (Table 4).
A number of inconclusive samples were obtained from study 
subjects (Table 3). A high signal:noise ratio and cross-reactivity 
were factors that prevented adequate interpretation. In 16 of 
the 414 patients screened for JEV, the ELISA results fell above 
background noise and just below IgM positive. The WNV assays 
resulted in 14 of 241 samples with similar inconclusive readings. 
Cross-reactivity between the WNV and JEV ELISA assays was 
also an issue with 32 (up to 13%) samples that tested positive for 
both WNV and JEV exposure.
real-Time Pcr
Synthetic targets were developed for use as standards and con-
trols for the RT-PCR platform (Table 2). Targets were optimized 
to perform as well as or better than conventional plasmids 
TaBle 4 | Patients testing positive for exposure to dengue virus (DenV), 
West nile virus (WnV), and Japanese encephalitis virus (JeV) at each 
study site.
study site DenV WnV JeV
Karachi 53 8 21
Hyderabad 3 2 6
Mirpurkhas 6 4 1
Sukkur 0 0 1
Larkana 1 2 3
TaBle 3 | Patients testing positive for exposure to dengue virus (DenV), 
West nile virus (WnV), Japanese encephalitis virus (JeV), or flavivirus 
(JeV–WnV cross-reactive) detected in patients enrolled in five study sites 
in sind Province, Pakistan.
Positive negative inconclusive/ 
borderline
Total  
samples
% Positive
JEV 32 367 16 414 7.73
WNV 16 211 14 241 6.64
DENV 63 404 0 467 13.49
Flavivirus 32 382 0 414 7.73
TaBle 2 | synthetic Dna targets used for rT-Pcr.
Target gene Target sequence
DENV 1 NS5 TTCGGAAAGGCAAAAGGAAGTCGTGCTATATGGTACATGTGGCTGGGAGCACGCTTTCTAGAGTTCGAAGCTCTTGGTTTCATGAACGAA 
GATCACTGGTTCAGCAGAGAGAATTCACTCAGCGGAGTGGAA
DENV 2 E GCAGAGTTGACAGGCTATGGCACTGTCACGATGGAGTGCTCTCCGAGAACGGGCCTCGACTTCAATGAGATGGTGTTGCTGCAAATGGA 
AAATAAAGC
DENV 3 prM TGTCGGCATGGGACTGGACACACGCACCCAAACCTGGATGTCGGCTGAAGGAGCTTGGAGGCAAGTCGAGAAGGTAGAGACATGGGC 
CCTTAGG
DENV 4 prM ACTGTTTTCTTTGTCCTAATGATGCTAGTCGCCCCATCCTACGGAATGCGATGCGTAGGGGTAGGGAACAGAGACTTTGTGGAAGGAGTCT 
CGGGTGGAGCATGGGTCG
TaBle 1 | rT-Pcr primers and probes used for the detection of Dengue virus.
Forward 5′–3′ reverse 5′–3′ Probe 5′–3′
DENV 1 CAAAAGGAAGTCGYGCWATA CTGAGTGAATTCTCTCTRCTRAAC FAM–CATGTGGYTGGGAGCRCGC–BHQ-1
DENV 2 CAGGYTATGGCACYRTCACRAT CCATYTGCAGCARCACSATCTC FAM–CTCYCCRAGAACGGGCCTMGACTTCAA–BHQ-1
DENV 3 GGACTRGACACACGCACCCA CATGTCTCTACCTTCTCGACTTGYCT FAM–ACCTGGATGTCGGCTGAAGGAGCTTG–BHQ-1
DENV 4 TYRTYCTAATGATGCTRGTCG TCCACCYGAGACTCCTTCCA FAM–CGGAATGCGATGCGTAGGRGTAGGRA–BHQ-1
February 2016 | Volume 4 | Article 84
Khan et al. Undifferentiated Fever in Sindh Province, Pakistan
Frontiers in Public Health | www.frontiersin.org
(Figure 3) and the difference in percent efficiency was 10% or less 
for DENV1 and 3 and <20% for DENV2 and DEN4. In addition, 
we found that our plasmid controls were frequently >100% in 
efficiency (slope <−3.5).
DiscUssiOn
Arboviral infections have a global distribution; however, the 
burden of viral agents varies in different geographical regions. 
The true burden and epidemiology of arboviruses in Pakistan are 
not known as many of these infections, which present initially as 
a vague febrile illness, are often misdiagnosed.
The expansion of DENV in Pakistan has been notable in its 
intensity. Recently, DENV emerged in Karachi in Sindh, Pakistan 
affecting 3,640 patients with an estimated 40 deaths (12–14). 
WNV is an arbovirus undergoing expansion throughout the 
world. While it is similar to JEV in terms of syndromes, most 
human JEV exposure and illness is described in children (27). 
For WNV, people over the age of 55 years have the highest risk 
factors for neurological syndromes during the virus’ recent 
expansion throughout Europe (28). Comparative analysis of 
risk for concomitantly circulating JEV and WNV has not been 
performed. Recent evidence demonstrates a high amount of 
WNV activity in Pakistan in horses (20); however, there is limited 
information regarding recent human exposure and, to the best of 
our knowledge, the most commonly reported cause of neurologi-
cal arboviral disease would likely be JEV (20).
Dengue virus was the most frequently identified and wide-
spread flavivirus detected in enrolled patients. These data show 
that DENV was detected in nearly one-third of all patients in 
Karachi while it was found at much lower rates in other locations. 
This is most likely due to the fact that Karachi is an expansive 
urban environment with the ideal climate for the DENV vector 
Aedes aegypti. The other four sites displayed a much lower human 
exposure of arboviral diseases than Karachi, most likely because 
suitable conditions for the vector are absent. Flavivirus exposure 
was detected in only one patient living in Sukkur. This may be a 
function of vector biology or the low number of screened patients. 
Sukkur is a small, sparsely populated district where the climate is 
very hot, windy, and dry, which is not suited to most mosquitoes.
Commercial assays make field work in limited areas feasible. 
They are easy to use and results are easy to interpret. However, 
especially for WNV, the assay is expensive. As expected, there 
was significant cross-reactivity between WNV and JEV when 
using IgM ELISA kits. If JEV and WNV ELISA data are grouped 
as “flavivirus exposed,” roughly 13% of screened patients were 
positive. Consistent with the algorithm, all of the WNV and JEV 
samples will be tested by plaque reduction neutralization test 
(PRNT) to confirm which disease agent was present.
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This cooperative BEP with Pakistan shows that scientific and 
medical projects can be successful and rapidly established between 
academic professional of countries that have limited political 
relations. Relationships were enhanced through early discussions 
between partners that included cultural and scientific barriers to 
health to optimize scientific training and develop methods for 
clinical surveillance. Barriers to recruitment of patients included 
lack of understanding of basic clinical signs of arboviral diseases 
on the part of health-care professionals. This was remedied via 
focused training study personnel who were employed locally.
Supply and communication lines also needed to be addressed 
by investment of research time into questions that challenge 
issues of data transfer and cold-chain supply without the need 
for development of entirely new technologies. For assay develop-
ment, reagents and assays were developed to obviate the need for 
a cold-chain. In particular, it was determined that the BioRad 
chemistries could be shipped at ambient temperature and was 
confirmed by sending the reagents from the UF laboratory to 
the Aga Khan laboratory. When using plasmid technology, 
problems arose with reagent stability if shipping was interrupted 
(>3 weeks); thus, commercially manufactured real-time targets 
were used. These targets proved to be highly stable and exception-
ally cost-effective. This also decreased the need to send supplies 
on dry ice that offered a substantial decrease in shipping costs and 
increased the availability of other forms of freight.
One of the most common challenges faced in the establishment 
of this project centered on limited communication to establish 
the needs of the US–Pakistan collaborators themselves. Most 
communications were written and did not include face-to-face 
fact finding before embarking on training and teaching sessions. 
In addition, problems with computer-based communication and 
travel (both local and abroad) delayed development of laboratory 
expertise. At the study sites, basic mobile phone technology was 
relied upon to share patient cases with infectious disease experts 
and the availability of a freely hosted website greatly facilitated 
this. Differences in compliance requirements at both University 
and government levels posed significant obstacles for transfer of 
medical technology.
Despite these issues, many goals have been attained within the 
first year of establishment of this project; a collaborative envi-
ronment between a US-based University and a Pakistan-based 
University for the purposes of research and training exchange 
and a multisite network for arbovirus surveillance in humans 
across one of the largest and most populous provinces of Pakistan 
were established. US partners gained an understanding of the 
climatic, geographic, and cultural landscape of Pakistan and how 
this may contribute to arbovirus expansion. Finally, for the first 
time, preliminary assessment of the variety of several important 
arboviruses was determined indicating the need for continued 
surveillance and testing.
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